Cold & Cough Remedies (Pharmacies) - Iran

  • Iran
  • Revenue in the Cold & Cough Remedies market is projected to reach US$169.00m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 5.06%, resulting in a market volume of US$216.30m by 2029.
  • In global comparison, most revenue will be generated in China (US$7,826.00m in 2024).
  • In relation to total population figures, per person revenues of US$1.88 are generated in 2024.

Key regions: Canada, United Kingdom, United States, China, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies (Pharmacies) market in Iran has been experiencing significant growth in recent years.

Customer preferences:
Customers in Iran have shown a growing demand for Cold & Cough Remedies (Pharmacies) products. This can be attributed to several factors. Firstly, there is an increasing awareness among the population about the importance of maintaining good health and preventing illnesses. As a result, people are more willing to invest in products that can help them stay healthy and alleviate common cold and cough symptoms. Secondly, the changing lifestyle and dietary habits of the population have led to a higher prevalence of cold and cough-related illnesses. This has created a greater need for effective remedies to manage these conditions.

Trends in the market:
One of the key trends in the Cold & Cough Remedies (Pharmacies) market in Iran is the growing popularity of natural and herbal remedies. Customers are increasingly seeking products that are made from natural ingredients and have minimal side effects. This trend is driven by a desire for more holistic and sustainable healthcare solutions. As a result, pharmaceutical companies are introducing a wider range of natural and herbal remedies to cater to this demand. Another trend in the market is the increasing availability of over-the-counter (OTC) cold and cough remedies in pharmacies. Previously, customers had to visit a doctor to obtain a prescription for such products. However, with the growing number of OTC options available, customers can now easily purchase these remedies directly from pharmacies. This convenience factor has contributed to the growth of the market.

Local special circumstances:
Iran has a large population, which presents a significant market opportunity for Cold & Cough Remedies (Pharmacies) products. The country also has a relatively young population, with a high proportion of individuals in the working-age group. This demographic profile indicates a higher likelihood of cold and cough-related illnesses due to increased exposure to crowded work environments and public transportation. As a result, the demand for remedies to manage these conditions is expected to continue growing.

Underlying macroeconomic factors:
The growing Cold & Cough Remedies (Pharmacies) market in Iran can also be attributed to underlying macroeconomic factors. The country has experienced steady economic growth in recent years, which has led to an increase in disposable income among the population. This has made healthcare products, including cold and cough remedies, more affordable and accessible to a larger segment of the population. Additionally, the government has implemented policies to improve the healthcare infrastructure and promote the availability of essential medicines, further supporting the growth of the market. In conclusion, the Cold & Cough Remedies (Pharmacies) market in Iran is experiencing significant growth due to customer preferences for natural and herbal remedies, the increasing availability of OTC options, the local special circumstances of a large and young population, and underlying macroeconomic factors such as economic growth and government initiatives.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)